Bayesian reanalysis to assess consistency of TALAPRO-2 results in the Japanese subgroup with metastatic castration-resistant prostate cancer
Using Bayesian evidence synthesis with prespecified borrowing levels, the Japanese subgroup results were compatible in direction and magnitude with the overall TALAPRO-2 effect. These findings reduce uncertainty around local extrapolation; a dedicated randomized study would be required to establish efficacy independently in Japanese patients.
Authors
- Kohei Hirose (ORCID: https://orcid.org/0000-0001-6384-7071)
- Y. Fujii
- Hitoshi Masuda
- Motohiro Fujiwara
- Shugo Yajima
- Yosuke Yasuda
- Wei Chen
- Hiroshi Fukushima
- Akihiro Hirakawa
- Soichiro Yoshida
- Hajime Tanaka
- Kenji Tanabe
Institutions
- Tokyo Medical and Dental University (JP)
- National Cancer Center Hospital East (JP)
- Zigong First People's Hospital (CN)
- The University of Tokyo (JP)
- Teikyo University (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-12-29
- DOI
- https://doi.org/10.1093/jjco/hyaf219
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00